HemaSphere (Aug 2023)

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231

  • Margot Roeten,
  • Suzanne van Dijk,
  • Johan van Meerloo,
  • Zinia Kwidama,
  • Gaya Jenkins,
  • David Teachey,
  • Meenakshi Devidas,
  • Mignon Loh,
  • Gertjan Kaspers,
  • Sonja Zweegman,
  • Gerrit Jansen,
  • Terzah Horton,
  • Jacqueline Cloos

DOI
https://doi.org/10.1097/01.HS9.0000968228.81299.a0
Journal volume & issue
Vol. 7
p. e81299a0

Abstract

Read online

No abstracts available.